Last 12 months
Inside the activity.
1 purchase rows · 16 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 15 |
| Mar 2026 | 1 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 21, 2017 Filed Feb 23, 2017 16:03 UTC |
Dahan MichelSVP, Chief Business Officer
|
GrantStock Option (Right to buy) · Derivative | 62,500 | $10.14 Strike: $0.00 | $633,750.00 |
DisclosureSEC source: 0001562180-17-000883 · primarydocument.xml · derivative · entry 2 Dahan Michel · CIK 0001669737 · SVP, Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,500 Underlying: Common Stock · 62,500 shares Expires 2027-02-21 F2 · derivative.exercise_date: 25% of the shares underlying this option will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter. Read SEC document |
| February 21, 2017 Filed Feb 23, 2017 16:03 UTC |
Dahan MichelSVP, Chief Business Officer
|
GrantCommon Stock | 39,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-17-000883 · primarydocument.xml · nonDerivative · entry 1 Dahan Michel · CIK 0001669737 · SVP, Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,024 F1 · shares: The restricted stock units were granted by the Issuer pursuant to its 2014 Incentive Plan. One hundred percent of the restricted stock units will vest on the third anniversary of the grant date. Read SEC document |
| February 21, 2017 Filed Feb 23, 2017 16:01 UTC |
Amello JasonSVP, CFO & Treasurer
|
GrantStock Option (Right to buy) · Derivative | 47,500 | $10.14 Strike: $0.00 | $481,650.00 |
DisclosureSEC source: 0001562180-17-000878 · primarydocument.xml · derivative · entry 2 Amello Jason · CIK 0001451805 · SVP, CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,500 Underlying: Common Stock · 47,500 shares Expires 2027-02-21 F3 · derivative.exercise_date: 25% of the shares underlying this option will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter. Read SEC document |
| February 21, 2017 Filed Feb 23, 2017 16:01 UTC |
Amello JasonSVP, CFO & Treasurer
|
GrantCommon Stock | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-17-000878 · primarydocument.xml · nonDerivative · entry 1 Amello Jason · CIK 0001451805 · SVP, CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,637 F1 · shares: The restricted stock units were granted by the Issuer pursuant to its 2014 Incentive Plan. One hundred percent of the restricted stock units will vest on the third anniversary of the grant date. F2 · balance_after: The total amount of beneficial securities owned includes 1,500 shares of stock purchased on June 30, 2016 at $6.35 per share and 807 shares of stock purchased on December 31, 2016 at $6.48 per share in connection with the Issuer's Employee Stock Purchase Plan. Read SEC document |
| February 21, 2017 Filed Feb 23, 2017 21:02 UTC |
Tubridy Karen LSVP, Chief Development Officer
|
GrantStock Option (Right to buy) · Derivative | 36,500 | $10.14 Strike: $0.00 | $370,110.00 |
DisclosureSEC source: 0001562180-17-000882 · primarydocument.xml · derivative · entry 2 Tubridy Karen L · CIK 0001589888 · SVP, Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,500 Underlying: Common Stock · 36,500 shares Expires 2027-02-21 F2 · derivative.exercise_date: 25% of the shares underlying this option will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter. Read SEC document |
| February 21, 2017 Filed Feb 23, 2017 21:02 UTC |
Tubridy Karen LSVP, Chief Development Officer
|
GrantCommon Stock | 23,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-17-000882 · primarydocument.xml · nonDerivative · entry 1 Tubridy Karen L · CIK 0001589888 · SVP, Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,000 F1 · shares: The restricted stock units were granted by the Issuer pursuant to its 2014 Incentive Plan. One hundred percent of the restricted stock units will vest on the third anniversary of the grant date. Read SEC document |
| February 21, 2017 Filed Feb 23, 2017 21:02 UTC |
Hadas Nicole R.SVP, General Counsel, Sec.
|
GrantStock Option (Right to buy) · Derivative | 45,000 | $10.14 Strike: $0.00 | $456,300.00 |
DisclosureSEC source: 0001562180-17-000880 · primarydocument.xml · derivative · entry 2 Hadas Nicole R. · CIK 0001602396 · SVP, General Counsel, Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 45,000 shares Expires 2027-02-21 F2 · derivative.exercise_date: 25% of the shares underlying this option will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter. Read SEC document |
| February 21, 2017 Filed Feb 23, 2017 21:02 UTC |
Hadas Nicole R.SVP, General Counsel, Sec.
|
GrantCommon Stock | 28,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-17-000880 · primarydocument.xml · nonDerivative · entry 1 Hadas Nicole R. · CIK 0001602396 · SVP, General Counsel, Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,412 F1 · shares: The restricted stock units were granted by the Issuer pursuant to its 2014 Incentive Plan. One hundred percent of the restricted stock units will vest on the third anniversary of the grant date. Read SEC document |
| February 21, 2017 Filed Feb 23, 2017 21:02 UTC |
Maroni BradleySVP and Chief Medical Officer
|
GrantStock Option (Right to buy) · Derivative | 37,500 | $10.14 Strike: $0.00 | $380,250.00 |
DisclosureSEC source: 0001562180-17-000881 · primarydocument.xml · derivative · entry 2 Maroni Bradley · CIK 0001615599 · SVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,500 Underlying: Common Stock · 37,500 shares Expires 2027-02-21 F3 · derivative.exercise_date: 25% of the shares underlying this option will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter. Read SEC document |
| February 21, 2017 Filed Feb 23, 2017 21:02 UTC |
Maroni BradleySVP and Chief Medical Officer
|
GrantCommon Stock | 23,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-17-000881 · primarydocument.xml · nonDerivative · entry 1 Maroni Bradley · CIK 0001615599 · SVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,585 F1 · shares: The restricted stock units were granted by the Issuer pursuant to its 2014 Incentive Plan. One hundred percent of the restricted stock units will vest on the third anniversary of the grant date. F2 · balance_after: The total amount of beneficial securities owned includes 1,500 shares of stock purchased on June 30, 2016 at $6.35 per share and 726 shares of stock purchased on December 31, 2016 at $6.48 per share in connection with the Issuer's Employee Stock Purchase Plan. Read SEC document |
| February 21, 2017 Filed Feb 23, 2017 21:02 UTC |
Butler John P.Director · CEO and President
|
GrantStock Option (Right to buy) · Derivative | 190,000 | $10.14 Strike: $0.00 | $1,926,600.00 |
DisclosureSEC source: 0001562180-17-000879 · primarydocument.xml · derivative · entry 2 Butler John P. · CIK 0001591467 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 190,000 Underlying: Common Stock · 190,000 shares Expires 2027-02-21 F2 · derivative.exercise_date: 25% of the shares underlying this option will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter. Read SEC document |
| February 21, 2017 Filed Feb 23, 2017 21:02 UTC |
Butler John P.Director · CEO and President
|
GrantCommon Stock | 119,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-17-000879 · primarydocument.xml · nonDerivative · entry 1 Butler John P. · CIK 0001591467 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 317,780 F1 · shares: The restricted stock units were granted by the Issuer pursuant to its 2014 Incentive Plan. One hundred percent of the restricted stock units will vest on the third anniversary of the Grant Date. Read SEC document |
| January 19, 2017 Filed Jan 23, 2017 21:10 UTC |
Butler John P.Director · CEO and President
|
Exercise / conversionStock Option (Right to buy) · Derivative | 20,000 | $0.00 Strike: $0.47 | $0.00 |
DisclosureSEC source: 0001562180-17-000318 · primarydocument.xml · derivative · entry 2 Butler John P. · CIK 0001591467 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 387,000 Underlying: Common Stock · 20,000 shares Expires 2023-09-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 25% of this option vested on September 16, 2014. The remaining shares vest in equal monthly installments through September 1, 2017. Read SEC document |
| January 19, 2017 Filed Jan 23, 2017 21:10 UTC |
Butler John P.Director · CEO and President
|
Exercise / conversionCommon Stock | 20,000 | $0.47 | $9,400.00 |
DisclosureSEC source: 0001562180-17-000318 · primarydocument.xml · nonDerivative · entry 1 Butler John P. · CIK 0001591467 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 373,480 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This transaction represents the acquisition of common stock as a result of the exercise and hold of derivative securities reported in Table II. F2 · balance_after: The total amount of beneficial securities includes 1,500 shares of stock purchased on June 30, 2016 at $6.35 per share and 807 shares of stock purchased on December 30, 2016 at $6.48 per shares in connection with the Issuer's Employee Stock Purchase Plan. Read SEC document |
| January 03, 2017 Filed Jan 3, 2017 21:02 UTC |
Nash DuaneDirector
|
SaleCommon Stock | 1,980 | $10.46 | $20,711.00 |
DisclosureSEC source: 0001562180-17-000081 · primarydocument.xml · nonDerivative · entry 1 Nash Duane · CIK 0001591098 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,668 F1 · security: 47,525 shares of restricted stock (as adjusted from 27,157 shares prior to the 1.75-for-1 stock split effected on March 6, 2014) were awarded on December 23, 2013. Fifty percent of the shares vested on December 23, 2014. The remaining fifty percent vest ratably on the first day of each calendar quarter over three years from the first anniversary of the grant date until fully vested, assuming continued service through the applicable vesting date. F2 · shares: Shares sold by reporting person pursuant to a 10b5-1 plan in connection with the vesting of restricted stock pursuant to the December 23, 2013 award described in footnote 1. F3 · price: The price reported in this Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $10.42 to $10.58, inclusive. The reporting person undertakes to provide Issuer, any security holder of Issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote. Read SEC document |
| January 01, 2017 Filed Jan 3, 2017 16:02 UTC |
Dahan MichelSVP, Chief Business Officer
|
SaleCommon Stock | 1,629 | $10.49 | $17,089.19 |
DisclosureSEC source: 0001562180-17-000082 · primarydocument.xml · nonDerivative · entry 1 Dahan Michel · CIK 0001669737 · SVP, Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,524 F1 · shares: Shares sold by reporting person to pay taxes in connection with the vesting of restricted stock pursuant to a December 23, 2013 award. Twenty-five percent of the shares vested on December 2, 2014, and the remaining shares vest in equal quarterly installments through October 1, 2017. Read SEC document |
| January 01, 2017 Filed Jan 3, 2017 21:01 UTC |
Hadas Nicole R.SVP, General Counsel, Sec.
|
SaleCommon Stock | 1,810 | $10.49 | $18,987.99 |
DisclosureSEC source: 0001562180-17-000080 · primarydocument.xml · nonDerivative · entry 1 Hadas Nicole R. · CIK 0001602396 · SVP, General Counsel, Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,912 F1 · shares: Shares sold by reporting person to pay taxes in connection with the vesting of restricted stock pursuant to a December 23, 2013 award. Twenty-five percent of the shares vested on December 2, 2014, and the remaining shares vest in equal quarterly installments through October 1, 2017. F2 · balance_after: The total amount of beneficial securities includes 807 shares of stock purchased on December 30, 2016 at $6.48 per share in connection with the Issuer's Employee Stock Purchase Plan. Read SEC document |
| November 30, 2016 Filed Dec 2, 2016 21:05 UTC |
Tubridy Karen LSVP, Chief Development Officer
|
GrantStock Option (Right to buy) · Derivative | 130,000 | $0.00 Strike: $8.61 | $0.00 |
DisclosureSEC source: 0001562180-16-003658 · primarydocument.xml · derivative · entry 1 Tubridy Karen L · CIK 0001589888 · SVP, Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,000 Underlying: Common Stock · 130,000 shares Expires 2026-11-30 F1 · derivative.exercise_date: This option will vest as to 25% of the shares of common stock subject to the award on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter. Read SEC document |
| October 03, 2016 Filed Oct 4, 2016 20:12 UTC |
Nash DuaneDirector
|
SaleCommon Stock | 1,981 | $8.96 | $17,746.00 |
DisclosureSEC source: 0001562180-16-003208 · primarydocument.xml · nonDerivative · entry 1 Nash Duane · CIK 0001591098 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,648 F1 · security: 47,525 shares of restricted stock (as adjusted from 27,157 shares prior to the 1.75-for-1 stock split effected on March 6, 2014) were awarded on December 23, 2013. Fifty percent of the shares vested on December 23, 2014. The remaining fifty percent vest ratably on the first day of each calendar quarter over three years from the first anniversary of the grant date until fully vested, assuming continued service through the applicable vesting date. F2 · shares: Shares sold by reporting person pursuant to a 10b5-1 plan to pay taxes in connection with the vesting of restricted stock pursuant to the December 23, 2013 award described in footnote 1. F3 · price: The price reported in this Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $8.88 to $9.00, inclusive. The reporting person undertakes to provide Issuer, any security holder of Issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote. Read SEC document |
| October 01, 2016 Filed Oct 4, 2016 16:12 UTC |
Dahan MichelSVP, Chief Business Officer
|
SaleCommon Stock | 1,401 | $8.95 | $12,545.67 |
DisclosureSEC source: 0001562180-16-003207 · primarydocument.xml · nonDerivative · entry 1 Dahan Michel · CIK 0001669737 · SVP, Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,153 F1 · shares: Shares sold by reporting person to pay taxes in connection with the vesting of restricted stock pursuant to a December 23, 2013 award. Twenty-five percent of the shares vested on December 2, 2014, and the remaining shares vest in equal quarterly installments through December 2, 2017. Read SEC document |
| October 01, 2016 Filed Oct 4, 2016 20:12 UTC |
Hadas Nicole R.SVP, General Counsel, Sec.
|
SaleCommon Stock | 1,556 | $8.95 | $13,933.67 |
DisclosureSEC source: 0001562180-16-003206 · primarydocument.xml · nonDerivative · entry 1 Hadas Nicole R. · CIK 0001602396 · SVP, General Counsel, Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,915 F1 · shares: Shares sold by reporting person to pay taxes in connection with the vesting of restricted stock pursuant to a December 23, 2013 award. Twenty-five percent of the shares vested on December 2, 2014, and the remaining shares vest in equal quarterly installments through December 2, 2017. Read SEC document |
| July 28, 2016 Filed Feb 10, 2017 21:04 UTC |
Butler John P.Director · CEO and President
|
GiftCommon Stock | 58,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-17-000613 · primarydocument.xml · nonDerivative · entry 2 Butler John P. · CIK 0001591467 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Indirect · GRAT - Spouse Disclosed balance after: 58,400 F2 · shares: Of the shares tranferred by the reporting person on July 28, 2016, 58,400 were contributed to the Dorothy Butler 2016 GRAT, of which the reporting person's wife serves as trustee. F2 · balance_after: Of the shares tranferred by the reporting person on July 28, 2016, 58,400 were contributed to the Dorothy Butler 2016 GRAT, of which the reporting person's wife serves as trustee. Read SEC document |
| July 28, 2016 Filed Feb 10, 2017 21:04 UTC |
Butler John P.Director · CEO and President
|
GiftCommon Stock | 116,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-17-000613 · primarydocument.xml · nonDerivative · entry 1 Butler John P. · CIK 0001591467 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 198,280 F1 · shares: On July 28, 2016, the reporting person made the following transfers for estate planning purposes: 58,400 shares were transferred to the Dorothy Butler 2016 GRAT, 29,200 shares were transferred to the Dorothy Butler 2016 Irrevocable Trust, and 29,200 shares were transferred to the John P. Butler 2016 Irrevocable Trust. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.